EID Parry (India) Ltd
EID Parry (India) Ltd
Fast Moving Consumer GoodsEID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]
EID Parry trades at an attractive PE of 9.1x with strong TTM sales growth of 22%, but declining profitability (-3% TTM profit growth), low ROE of 8% last year, and a sharp 26% stock correction in the past year warrant caution. The valuation is undemanding but fundamental momentum is weakening.
Key Fundamentals
MicrocapFertilizersChemicalsTechnical Indicators
Key Insights
Weaknesses
3- Company has a low return on equity of 10.2% over last 3 years.
- Dividend payout has been low at 4.71% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.10%
Growth Rate
AI Analysis — Bull vs Bear
EID Parry trades at an attractive PE of 9.1x with strong TTM sales growth of 22%, but declining profitability (-3% TTM profit growth), low ROE of 8% last year, and a sharp 26% stock correction in the past year warrant caution. The valuation is undemanding but fundamental momentum is weakening.
- Attractive valuation with PE of 9.1x, significantly below FMCG sector average of 40-50x, offering margin of safety
- Strong TTM revenue growth of 22% indicates robust top-line momentum and demand recovery
- Price-to-book of 1.43x is reasonable for a company with established sugar and nutraceuticals business
- 10-year compounded profit CAGR of 36% demonstrates long-term earnings power and scalability
- 5-year compounded sales CAGR of 16% shows consistent revenue compounding over medium term
- 100% of analysts (1 out of 1) have a buy rating on the stock
- Market cap of Rs 12,791 crore provides reasonable liquidity and mid-cap stability
- Stock has declined 26% in the last 1 year, indicating significant negative price momentum
- TTM profit growth is negative at -3%, showing margin compression despite strong revenue growth
- 3-year compounded profit CAGR is -9%, reflecting sustained earnings deterioration
- ROE has declined from 12% (5-year average) to just 8% last year, signaling weakening capital efficiency
- Dividend payout is extremely low at 4.71% of profits over last 3 years, poor shareholder returns
- Promoter holding has decreased by 3.10% over last 3 years, raising governance concerns
- Dividend yield of only 0.57% offers minimal income support during periods of capital erosion
- 3-year sales CAGR of just 3% suggests the recent 22% TTM growth may not be sustainable
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q4 loss and refinery closure Jun 02
Q4FY26 net loss of ₹33,330 lakh driven by exceptional items and ₹293 crore refinery loss. Company infusing ₹600 crore into PSRIPL to meet loan obligations by June 30, 2026.
- FY26 profit sharply impacted Jun 02
Consolidated FY26 net profit fell to ₹56,954 lakh as Q4 losses and refinery shutdown weighed on full-year results.
- Pivot to higher-margin sweeteners Jun 02
Management recalibrating CPG strategy towards higher-margin sweeteners and focusing on cost efficiency post-refinery exit.
- Trading window closed July 1 Jun 23
EID Parry shuts trading window from July 1 until 48 hours after Q1FY27 results per SEBI insider trading regulations.
- ₹62.71 Cr block trade on NSE Jun 09
Approximately 865,136 shares traded in a single block at ₹724.90 per share, totalling ₹62.71 crores, suggesting institutional activity.
TL;DR: EID Parry faces near-term pain from the PSRIPL refinery closure, which drove a Q4 loss and requires a ₹600 crore cash infusion by end-June 2026. On the positive side, management is pivoting towards higher-margin sweeteners and tightening cost controls. Institutional block trade activity suggests continued large-investor engagement. The trend is stabilising but capital allocation pressure from the refinery wind-down remains a key risk into FY27.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6,860 | 7,026 | 9,059 | 7,770 | 5,557 | 6,747 | 9,330 | 8,720 | 6,811 | 8,724 | 11,624 | 10,312 | 7,882 |
| Expenses | 6,245 | 6,363 | 8,006 | 7,358 | 5,098 | 6,279 | 8,372 | 8,027 | 6,298 | 7,918 | 10,427 | 9,477 | 7,271 |
| Operating Profit | 615 | 664 | 1,053 | 412 | 459 | 468 | 959 | 694 | 513 | 805 | 1,198 | 835 | 611 |
| OPM % | 9% | 9% | 12% | 5% | 8% | 7% | 10% | 8% | 8% | 9% | 10% | 8% | 8% |
| Other Income | 5 | -11 | 151 | 41 | 123 | 60 | 69 | 117 | 459 | 90 | 151 | 60 | -430 |
| Interest | 87 | 82 | 74 | 53 | 86 | 84 | 94 | 99 | 96 | 104 | 129 | 103 | 119 |
| Depreciation | 105 | 94 | 101 | 112 | 113 | 117 | 123 | 130 | 142 | 176 | 158 | 204 | 226 |
| PBT | 428 | 477 | 1,029 | 288 | 382 | 327 | 811 | 582 | 735 | 615 | 1,062 | 588 | -162 |
| Tax % | 33% | 32% | 24% | 25% | 23% | 31% | 27% | 29% | 27% | 25% | 28% | 26% | 77% |
| Net Profit | 287 | 325 | 782 | 217 | 294 | 226 | 592 | 416 | 539 | 464 | 766 | 437 | -287 |
| EPS in Rs | 10.08 | 6.13 | 25.48 | 6.66 | 12.41 | 5.14 | 17.21 | 10.97 | 16.12 | 13.85 | 23.86 | 13.05 | -18.74 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13,952 | 15,358 | 14,391 | 15,373 | 16,556 | 17,129 | 18,556 | 23,521 | 35,244 | 29,413 | 31,609 | 38,534 |
| Expenses | 12,938 | 14,517 | 12,965 | 14,068 | 15,105 | 15,242 | 16,467 | 21,146 | 32,088 | 26,825 | 28,975 | 35,085 |
| Operating Profit | 1,014 | 841 | 1,426 | 1,305 | 1,450 | 1,887 | 2,089 | 2,375 | 3,156 | 2,588 | 2,633 | 3,450 |
| OPM % | 7% | 5% | 10% | 8% | 9% | 11% | 11% | 10% | 9% | 9% | 8% | 9% |
| Other Income | 105 | 179 | 159 | 150 | 83 | 129 | 17 | 240 | 83 | 304 | 706 | -129 |
| Interest | 420 | 451 | 417 | 336 | 425 | 430 | 236 | 152 | 298 | 295 | 372 | 454 |
| Depreciation | 244 | 250 | 248 | 251 | 272 | 319 | 332 | 334 | 376 | 421 | 512 | 763 |
| PBT | 455 | 319 | 920 | 868 | 837 | 1,266 | 1,539 | 2,129 | 2,564 | 2,175 | 2,455 | 2,103 |
| Tax % | 39% | 45% | 23% | 40% | 48% | 30% | 35% | 26% | 29% | 26% | 28% | 34% |
| Net Profit | 276 | 175 | 708 | 517 | 438 | 889 | 1,000 | 1,574 | 1,828 | 1,618 | 1,773 | 1,380 |
| EPS in Rs | 6.64 | 1.96 | 29.61 | 14.45 | 8.67 | 26.43 | 25.26 | 51.12 | 53.37 | 50.68 | 49.41 | 32.02 |
| Div. Payout % | 89% | 0% | 14% | 21% | 35% | 0% | 0% | 22% | 18% | 8% | 0% | 6% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 2,209 | 2,370 | 2,733 | 2,952 | 3,110 | 3,502 | 4,565 | 5,308 | 6,067 | 7,040 | 7,918 | 8,748 |
| Borrowings | 4,823 | 5,144 | 3,923 | 4,470 | 5,125 | 4,347 | 1,229 | 1,259 | 1,618 | 1,740 | 2,704 | 3,528 |
| Other Liabilities | 5,849 | 6,600 | 6,691 | 7,088 | 7,649 | 7,069 | 7,444 | 9,358 | 11,076 | 12,688 | 13,731 | 16,960 |
| Total Liabilities | 12,899 | 14,131 | 13,364 | 14,528 | 15,901 | 14,936 | 13,257 | 15,943 | 18,778 | 21,487 | 24,371 | 29,254 |
| Fixed Assets | 3,476 | 3,343 | 3,297 | 3,197 | 3,077 | 3,858 | 3,583 | 3,763 | 3,889 | 4,896 | 6,148 | 8,292 |
| CWIP | 75 | 77 | 39 | 54 | 203 | 85 | 206 | 160 | 486 | 520 | 422 | 304 |
| Investments | 369 | 688 | 569 | 430 | 418 | 413 | 453 | 563 | 609 | 1,275 | 1,453 | 2,477 |
| Other Assets | 8,979 | 10,022 | 9,459 | 10,847 | 12,203 | 10,579 | 9,014 | 11,456 | 13,794 | 14,796 | 16,348 | 18,181 |
| Total Assets | 12,899 | 14,131 | 13,364 | 14,528 | 15,901 | 14,936 | 13,257 | 15,943 | 18,778 | 21,487 | 24,371 | 29,254 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 222 | 437 | 1,969 | 259 | -52 | 1,986 | 4,771 | 2,278 | 359 | 1,974 | 1,936 | 1,542 |
| Investing | -307 | -192 | -148 | 13 | -357 | -282 | -548 | -1,732 | 487 | -1,740 | -2,783 | -174 |
| Financing | -142 | -221 | -1,842 | 42 | 34 | -1,769 | -3,598 | -499 | -184 | -497 | 74 | -551 |
| Net Cash Flow | -227 | 23 | -21 | 314 | -375 | -65 | 625 | 47 | 661 | -263 | -772 | 817 |
| Free Cash Flow | 35 | 233 | 1,839 | 82 | -396 | 1,628 | 4,455 | 1,845 | -370 | 1,051 | 1,323 | 5 |
| CFO/OP | 36 | 73 | 160 | 48 | 24 | 126 | 252 | 117 | 33 | 101 | 102 | 67 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 45 | 49 | 47 | 43 | 46 | 45 | 17 | 9 | 8 | 23 | 20 | 22 |
| Inventory Days | 138 | 124 | 127 | 134 | 175 | 131 | 112 | 111 | 81 | 112 | 101 | 107 |
| Days Payable | 141 | 145 | 170 | 174 | 172 | 141 | 124 | 114 | 84 | 121 | 113 | 116 |
| Cash Conversion Cycle | 42 | 27 | 4 | 3 | 49 | 35 | 6 | 6 | 5 | 14 | 8 | 13 |
| Working Capital Days | -1 | 2 | 15 | 4 | 17 | 36 | 45 | 29 | 27 | 27 | 14 | 40 |
| ROCE % | 11% | 9% | 16% | 16% | 14% | 18% | 21% | 26% | 27% | 20% | 17% | 18% |
Documents
Frequently Asked Questions about EID Parry (India) Ltd
What does EID Parry (India) Ltd do?
Where is EID Parry (India) Ltd (EIDPARRY) listed?
Which sector does EID Parry (India) Ltd belong to?
What is the market capitalisation of EID Parry (India) Ltd?
What is the PE ratio of EID Parry (India) Ltd?
What is the 52-week high and low of EID Parry (India) Ltd?
Does EID Parry (India) Ltd pay dividends?
What is the Return on Equity (ROE) of EID Parry (India) Ltd?
How can I research EID Parry (India) Ltd on Tapetide?
Company Information
EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]